Stockscreener 앱 받기
104.26
1.79%
-1.90
전일 마감가:
$106.16
열려 있는:
$106.43
하루 거래량:
346.48K
Relative Volume:
0.55
시가총액:
$8.10B
수익:
-
순이익/손실:
$-224.29M
주가수익비율:
-26.73
EPS:
-3.9
순현금흐름:
$-185.06M
1주 성능:
-0.75%
1개월 성능:
+1.59%
6개월 성능:
+22.01%
1년 성능:
+37.20%
1일 변동 폭
$104.26
$107.80
1주일 범위
$97.42
$108.65
52주 변동 폭
$55.53
$112.88
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
NUVL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
104.26 | 8.24B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-12 | 개시 | Canaccord Genuity | Buy |
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-10-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-09-03 | 개시 | Raymond James | Outperform |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-03-14 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-10-24 | 개시 | UBS | Neutral |
| 2024-08-29 | 개시 | Barclays | Overweight |
| 2024-04-17 | 개시 | Jefferies | Buy |
| 2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | 재개 | Guggenheim | Buy |
| 2024-02-23 | 개시 | Robert W. Baird | Outperform |
| 2023-09-27 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | SVB Securities | Market Perform |
| 2023-07-24 | 개시 | Guggenheim | Buy |
| 2023-01-18 | 개시 | Wedbush | Outperform |
| 2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Investment Report: Is Nuvalent Inc benefiting from innovation trendsTreasury Yields & Breakout Confirmation Alerts - baoquankhu1.vn
SG Americas Securities LLC Takes Position in Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent (NASDAQ:NUVL) Stock Price Up 7.3%Here's Why - MarketBeat
Nuvalent stock jumps as FDA review clock sharpens focus on 2026 launch plans - TechStock²
FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment By Investing.com - Investing.com Nigeria
Understanding Momentum Shifts in (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Stock Price Down 6.7%What's Next? - MarketBeat
Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones - Investing News Network
Nuvalent, Inc. (NUVL) Stock Analysis: Exploring A Promising 34.89% Upside In Biotech - DirectorsTalk Interviews
Downgrade Watch: How buybacks impact Nuvalent Inc stock valueJuly 2025 Action & High Accuracy Buy Signal Tips - Bộ Nội Vụ
This Insider Has Just Sold Shares In Nuvalent - simplywall.st
Aug Intraday: Will Nuvalent Inc. stock outperform growth indexesJuly 2025 Chart Watch & Fast Entry High Yield Tips - Улправда
Will Nuvalent Inc. stock outperform tech sector in 2025Trend Reversal & Capital Efficient Trade Techniques - Улправда
How Nuvalent Inc. stock performs in weak economy2025 AllTime Highs & Low Risk Entry Point Guides - Улправда
Will Nuvalent Inc. stock return to pre crisis levelsJuly 2025 Snapshot & Real-Time Volume Trigger Notifications - Улправда
How buybacks impact Nuvalent Inc. stock valueRate Hike & Community Trade Idea Sharing Platform - Улправда
Is Nuvalent Inc. stock in correction or buying zone2025 Short Interest & AI Based Buy and Sell Signals - Улправда
Is Nuvalent Inc. stock a defensive play in 2025Dividend Hike & Daily Growth Stock Investment Tips - Улправда
Nuvalent CSO Pelish sells shares worth $501,752 By Investing.com - Investing.com South Africa
Will Nuvalent’s Momentum Continue? - StocksToTrade
Nuvalent (NASDAQ:NUVL) Insider Sells $251,547.24 in Stock - MarketBeat
Nuvalent (NASDAQ:NUVL) CFO Sells $309,065.96 in Stock - MarketBeat
Insider Selling: Nuvalent (NASDAQ:NUVL) Insider Sells 2,496 Shares of Stock - MarketBeat
Nuvalent (NASDAQ:NUVL) Insider Sells $412,247.52 in Stock - MarketBeat
Nuvalent (NASDAQ:NUVL) Insider Sells $309,065.96 in Stock - MarketBeat
Nuvalent CSO Pelish sells shares worth $501,752 - Investing.com India
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock - Investing.com India
Nuvalent (NUVL) chief development officer sells $721k in stock By Investing.com - Investing.com Canada
Nuvalent initiated with a Buy at Canaccord - MSN
Aug Spikes: Will Nuvalent Inc stock outperform tech sector in 2025July 2025 Drop Watch & Expert Curated Trade Ideas - moha.gov.vn
James Richard Porter Sells 17,890 Shares of Nuvalent (NASDAQ:NUVL) Stock - MarketBeat
Nuvalent's Chief Legal Officer Sells 10,000 Shares - TradingView — Track All Markets
Nuvalent, Inc. Reports Q3 2025 Progress and Financials - MSN
Avoiding Lag: Real-Time Signals in (NUVL) Movement - Stock Traders Daily
Bear Alert: How Nuvalent Inc stock performs in weak economyWeekly Stock Analysis & Daily Profit Maximizing Tips - moha.gov.vn
Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Nuvalent Earnings Notes - Trefis
What's Going On With Royalty Pharma Stock Wednesday? - Benzinga
PRN_FinancialWrapper | PR NewswireNuvalent, Inc.Class A Common Stock (Nasdaq:NUVL) Stock Quote - FinancialContent
Towards 2026, Focusing on Three High-Potential Biotechnology Companies - NAI500
Nuvalent’s royalty interest acquired by Royalty Pharma - MSN
3 Biotech Stocks With Major 2026 Catalysts - Nasdaq
Truist Securities Initiates Coverage of Nuvalent (NUVL) with Buy Recommendation - MSN
Nuvalent (NUVL): Assessing an Expensive-Looking Valuation After a Strong Multi-Year Share Price Run - Yahoo Finance
Nuvalent, Inc. $NUVL Shares Bought by Voya Investment Management LLC - MarketBeat
Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
Nuvalent files for mixed shelf offering size not disclosedSEC filing - marketscreener.com
Technical Reactions to NUVL Trends in Macro Strategies - Stock Traders Daily
What drives Nuvalent Inc stock priceStock Buyback Updates & Follow Top Performers in the Community - earlytimes.in
Why Nuvalent Inc. stock remains a top recommendationJuly 2025 WrapUp & High Accuracy Swing Trade Signals - Улправда
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nuvalent Inc 주식 (NUVL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Pelish Henry E. | Chief Scientific Officer |
Jan 05 '26 |
Sale |
97.32 |
2,496 |
242,905 |
68,552 |
| Noci Darlene | Chief Development Officer |
Jan 05 '26 |
Sale |
97.32 |
4,236 |
412,239 |
43,798 |
| Noci Darlene | Chief Development Officer |
Jan 06 '26 |
Sale |
97.16 |
3,181 |
309,081 |
40,617 |
| Miller Deborah Ann | Chief Legal Officer |
Jan 05 '26 |
Sale |
97.32 |
4,363 |
424,598 |
44,723 |
| Miller Deborah Ann | Chief Legal Officer |
Jan 06 '26 |
Sale |
97.16 |
2,589 |
251,560 |
42,134 |
| Turner Christopher Durant | Chief Medical Officer |
Jan 05 '26 |
Sale |
97.32 |
4,236 |
412,239 |
58,311 |
| Turner Christopher Durant | Chief Medical Officer |
Jan 06 '26 |
Sale |
97.16 |
3,181 |
309,081 |
55,130 |
| Balcom Alexandra | Chief Financial Officer |
Jan 05 '26 |
Sale |
97.32 |
4,236 |
412,239 |
84,914 |
| Balcom Alexandra | Chief Financial Officer |
Jan 06 '26 |
Sale |
97.16 |
3,181 |
309,081 |
81,733 |
| Porter James Richard | President and CEO |
Jan 05 '26 |
Sale |
97.32 |
17,890 |
1,741,016 |
288,172 |
4.73%
0.92%
자본화:
|
볼륨(24시간):